MedPath

BAVENCIO 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

BAVENCIO 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

171214001IP

Prescription Type

Uso Hospitalario

Authorization Date

Sep 16, 2022

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number171214001IP
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

AVELUMABActive
Quantity: 20 mg/ml
Name: AVELUMAB

ATC CLASSIFICATION (3)

L01F
L01FF
L01FF04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.